PNU-159682 CAS: 202350-68-3, a potent Nemorubicin-derived anthracycline metabolite, excels as a DNA topoisomerase II inhibitor, surpassing Doxorubicin in ADC synthesis and emerging as a prime candidate for overcoming drug resistance through nanocell technology.
Payloads and Linker modified Payloads
感谢您来到爆牛贸易,请为我们留言或者使用以下方式联系我们,我们将尽快给您回复,并为您提供最真诚的服务,谢谢。